QLS-111 added to latanoprost drove up to 3.6 mmHg greater reduction in IOP as compared to latanoprost alone DEDHAM, Mass., February 05, 2025--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage ...

The drug in question, dubbed QLS‑111, has been created with Qlaris’ ATP-sensitive potassium channel modulator platform and is designed to lower intraocular pressure (IOP). The results ...

QLS-111 added to latanoprost drove up to 3.6 mmHg greater reduction in IOP as compared to latanoprost alone DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company ...

If implemented, this technology could buttress the operation of sensors and navigation systems, extend detection range, and greatly enhance computing power. But the real trick will be putting ...

Have you ever wondered how speed guns measure the speed of moving vehicles or how an athlete's sprint speed is recorded? Normally these speed sensors work with radar or laser technology to bounce back ...